A small molecule inhibits bacterial virulence by binding a conserved pocket in a regulatory protein.

Bacteria are becoming resistant to our standard antibiotics, creating an urgent health danger. Instead of killing bacteria directly, scientists are testing small molecules that disarm them by blocking virulence factorsvirulence factorsMolecules produced by a bacterium that help it cause disease., the tools germs use to cause disease. Researchers studied a small molecule called regacin. It acts as a potent inhibitor of RegA, a regulatory protein that turns on disease-causing genes in Citrobacter rodentium. RegA belongs to a large family of similar proteins found across many harmful human pathogens. The team determined how RegA looks at high resolution with and without regacin attached. They found that regacin docks directly inside a conserved pocket in RegA. By testing altered versions of this pocket, they confirmed these exact contact points are necessary to block the protein. This provides a blueprint to design drugs targeting related proteins in other dangerous bacteria.

Why it matters

Antibiotic resistance makes new approaches urgent. Instead of killing bacteria, antivirulence drugs stop them from causing disease, which may slow resistance. This study reveals a shared pocket in a family of regulators found in many dangerous bacteria, so one drug design could work across multiple pathogens.

Questions answered